Raphael Rabinowitz, MD
Tumor Lysis Syndrome; Hypercalcemia of Malignancy; Neutropenic Fever; Spinal Cord Compression; Sepsis; Myocardial Infarction; Congestive Heart Failure; COPD; GI Bleeds; Cirrhosis; Chronic Kidney Disease
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, University of Chicago, Pritzker School of Medicine
Internal Medicine - NYU Langone Health
As a night hospitalist, or nocturnist, at one of the pre-eminent cancer hospitals in the world, I specialize in the care of cancer patients who are acutely ill and require admission to the hospital. Many of the conditions I treat are complications of patients’ cancers or treatments, including tumor lysis syndrome, spinal cord compression, neutropenic fever, and hypercalcemia of malignancy that necessitate urgent evaluation and management. People with cancer often have multiple medical problems and present to the hospital with non-oncologic reasons for admission. I specialize in the comprehensive medical care of people with cancer, including heart attacks, heart failure, COPD, venous thromboembolism, GI bleeding, and end-stage renal disease. The ability to care for a breadth of conditions afflicting multiple organ systems and the interactions between these systems are what draw me to practice hospital medicine. Furthermore, I’m drawn to the institutional commitment to patient-centered care through upholding patient preferences and compassionate communication that is foundational to the mission of MSK.
My research focuses on preparing trainees for commonly encountered hospital emergencies occurring overnight through simulation and feedback. To that end, I supervise transitional year interns undergoing internal medicine training and advance practice providers, paying particular attention to developing diagnostic approaches and management frameworks for common overnight events that occur in the hospital. Prompt recognition of a deteriorating patient can literally be the difference between life and death — a charge I take to heart every night I come to work.
Awards and Honors
- Pritzker School of Medicine Students Teaching Students Award (2017)
- Americorps Education Award (2012-2013)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Rabinowitz R, Farnan J, Hulland O, et al. Rounds Today: A Qualitative Study of Internal Medicine and Pediatrics Resident Perceptions. J Grad Med Educ. 2016;8(4):523-531. doi:10.4300/JGME-D-15-00106.1
Hulland O, Farnan J, Rabinowitz R, et al. What’s the Purpose of Rounds? A Qualitative Study Examining the Perceptions of Faculty and Students. J Hosp Med. 2017;12(11):892-897. doi:10.12788/jhm.2835
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Raphael Rabinowitz discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.